David Lorente
Downs Road, Surrey
Sutton Upon Derwent, ENG SM25PT, United Kingdom
Sutton Upon Derwent, ENG SM25PT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 14, 2025
PARP Inhibitors and Prostate Cancer: The Struggle To Separate the Grain from the Chaff.
Journal: European urology
Published: January 08, 2025
Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 04, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study.
Journal: European urology oncology
Published: July 15, 2023
Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study.
Journal: Melanoma research
Published: March 29, 2023
Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 08, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 07, 2022
Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer.
Journal: Frontiers in oncology
Published: July 06, 2022
Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer.
Journal: Cancers
Published: August 03, 2021
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma.
Journal: Neuro-oncology advances
Published: May 31, 2021
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.
Journal: Cancers
Published: March 12, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 27, 2021
Last Updated: 09/26/2026